Drug company Mayne Pharma is pushing back against US-based Cosette Pharmaceutical's second attempt to terminate a proposed ...

Israel’s strike on Iran rattled markets and raised fears of oil disruption — another reminder that in today’s economy, ...

The private credit giant is embarking on an ambitious push into consumer lending in a bid to increase its scale and diversify ...

Former iflix CEO Mark Britt has emerged from stealth mode with tmrw, an AI-driven preventive health platform which has ...

The Australian sharemarket closed lower as huge gains in the energy and utilities sectors - buoyed by advancing oil prices as ...

Vulcan Energy has secured approval and building permits for the 30 megawatt (MW) geothermal renewable energy plant and ...

Australian shares are set to open higher after all three US indices closed higher overnight, spurred by a 13% jump by ...

The news: A Google Cloud outage took down multiple popular online services including Spotify, Discord, and Google, with tens ...

Bell Potter has placed a 'sell' rating on Cettire after the luxury retail platform missed earnings estimates on Thursday, ...

ASX-listed gold producers gained as investors turned to the safe haven metal after Israel launched a series of attacks on Iran on Friday morning.

Clarity Pharmaceuticals has announced positive topline results from a phase two diagnostic trial, which found its cancer radiopharmaceutical Cu-SAR-Bombesin is effective in detecting prostate cancer ...

Chime Financial’s shares jumped as much as 66.4% in its trading debut after raising US$864 million ($1.32 billion) in an ...